Phase 3 PROSERA study

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Gossamer Bio Faces Class Action Over Allegedly Misleading Phase 3 Trial Data

Class action lawsuit filed against Gossamer Bio for alleged false statements regarding Phase 3 PROSERA study results and concealed trial design issues at Latin American sites.
GOSSsecurities fraudclass action lawsuit